Navigation Links
Kensey Nash to Participate in the RBC Capital Markets Healthcare Conference
Date:12/7/2007

EXTON, Pa., Dec 7 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (Nasdaq: KNSY) is scheduled to participate in a panel discussion on "Helping the Body Regenerate Bone & Tissue" at the 2007 RBC Capital Markets Healthcare Conference.

Douglas G. Evans, Kensey Nash's COO, will participate in the panel discussion on Thursday, December 13th at 8:00 a.m. ET in The Westin New York at Times Square in New York. The conference is by invitation only, however individuals can listen to the live and archived presentation at http://www.wsw.com/webcast/rbc84/panel20 or by visiting the Company's website (http://www.kenseynash.com).

About Kensey Nash Corporation. Kensey Nash Corporation is a leading medical technology company providing innovative solutions and technologies for a wide range of medical procedures. The Company provides an extensive range of products into multiple medical markets, primarily in the endovascular, sports medicine and spine markets. Many of the products are based on the Company's significant expertise in the design, development, manufacturing and processing of absorbable biomaterials, which has led to partnerships to commercialize technologies. Kensey Nash has also commercialized a series of innovative products through its own direct endovascular sales force. The Company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc.


'/>"/>
SOURCE Kensey Nash Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Kensey Nash to Present at the Sidoti Sixth Annual West Coast Emerging Growth Institutional Investor Forum Conference
2. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
3. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference
4. China Medical Technologies to Participate in Credit Suisses 2007 Asian Technology Conference
5. Angiotech to participate in UBS Global Life Sciences Conference
6. Transcept Pharmaceuticals to Participate in Middle-of-the-Night (MOTN) Insomnia Investor Panel
7. Vicus Therapeutics Chief Executive Officer to Participate in BIOTECH 2007 Expert Panels
8. Genzyme to Participate in FDA Advisory Committee Meeting on the Use of Phosphate Binders in Chronic Kidney Disease
9. MacroChem To Participate in PIPEs Conference October 18th and 19th in New York City
10. Lev Pharmaceuticals Invites You to Participate in its Q307 Earnings Results Conference Call and Webcast
11. Angiotech to participate in Bank of America 2007 Credit Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... and Liege, Belgium (PRWEB) , ... January 17, ... ... solutions for sample preparation and epigenetics research, recently announced a collaboration with the ... a high-sensitivity DNA amplification method for library preparation, following the company’s successful launch ...
(Date:1/16/2017)... --  Valentin A. Pavlov, PhD , associate investigator, and ... of The Feinstein Institute for Medical Research ... nervous system regulates the immune system, which will help ... devices to treat disease and injury. The analysis is ... The paper examines various studies which further define the ...
(Date:1/14/2017)... , Jan. 13, 2017  The Alliance for Safe ... response to FDA final guidance on biologic ... continued leadership in emphasizing the importance of distinct naming ... aware of the benefits biosimilars will bring to patients, ... Yet the portion of the Guidance dealing with ...
(Date:1/13/2017)... ... 13, 2017 , ... FireflySci has been busy rolling out ... diverse customer base. The latest entry in this field is a series of ... Bio-Rad. FireflySci is introducing three distinct varieties including a 10x1mm, 10x2 and 10x4 ...
Breaking Biology Technology:
(Date:12/16/2016)... YORK , Dec. 16, 2016 The global wearable ... USD 12.14 billion by 2021 from USD 5.31 billion in 2016, ... ... is mainly driven by technological advancements in medical devices, launch of ... rising preference for wireless connectivity among healthcare providers, and increasing focus ...
(Date:12/15/2016)... DUBLIN , Dec 15, 2016 ... Research and Markets has announced ... to their offering. The report forecasts the global military ... 2016-2020. The report has been prepared based on an ... market landscape and its growth prospects over the coming years. The report ...
(Date:12/15/2016)... "Increase in mobile transactions is driving the growth of ... expected to grow from USD 4.03 billion in 2015 ... of 29.3% between 2016 and 2022. The market is ... smart devices, government initiatives, and increasing penetration of e-commerce ... to grow at a high rate during the forecast ...
Breaking Biology News(10 mins):